Deb Ranjan Bnerjee

Scientist in Medicinal Chemistry/Chemical Biology I Assistant Professor @NIT Durgapur, India I Chromatin and Nucleosome Lover I Learning Twitter I

[Deb Ranjan Bnerjee @deb_ranjan2]

@PallasMerce @Naturcell @UBneuroscience @Farmacia_UB @UniBarcelona Congratulations

[Deb Ranjan Bnerjee @deb_ranjan2]

@Naturcell Congratulations

[Deb Ranjan Bnerjee @deb_ranjan2]

@Naturcell @ResearchGate Great

[Deb Ranjan Bnerjee @deb_ranjan2]

@Naturcell Congratulations

[ACS Publications Bio & Med Chem Content @ACSBioMed]

Inhibition of methyltransferase enzyme towards epigenetic therapeutics of Alzheimer’s disease. @deb_ranjan2 #G9a #Alzheimers

Read now in #ACSMedChemLett ➡ https://t.co/0YqamNTjav

[Deb Ranjan Bnerjee @deb_ranjan2]

I'm glad to share our latest research work, Repurposing of Raltitrexed as an Effective G9a/EHMT2 Inhibitor and Promising Anti-Alzheimer’s Agent | ACS Medicinal Chemistry Letters https://t.co/zA5eJu2HTe
Thanks, Team, especially @Naturcell

[Deb Ranjan Bnerjee @deb_ranjan2]

It is nice to see that our honorable chief Minister @MamataOfficial is visiting #Spain seeking collaboration. In the same time, my collaborator from Spain, Dr Christian @Naturcell of University of Barcelona, is acknowledging the benefit of our collaboration in his seminar❤️

[Deb Ranjan Bnerjee @deb_ranjan2]

@atanu_acharya1 @NIH @NIGMS @SUChemistry @SUBioInspired @ArtSciencesSU Congratulations

[Deb Ranjan Bnerjee @deb_ranjan2]

@Naturcell @UniBarcelona @Farmacia_UB Congratulations

[Deb Ranjan Bnerjee @deb_ranjan2]

@abhijit_MLab @serbonline Many of us travel to Delhi as we don't get response within time ...

[Deb Ranjan Bnerjee @deb_ranjan2]

I'm so delighted to inform that my 1st PhD student Subhabrata Mabhai defended his PhD thesis successfully today.
He is now on Dr Subhabrata Mabhai and I wish him best in his future endeavors...

[Deb Ranjan Bnerjee @deb_ranjan2]

Congratulations @Naturcell
And team for such pioneering research work on investigating the role of G9a (lysine methyltransferase) on #Alzheimer
Glad to be part of it.
https://t.co/GumsyhT4DO

[Deb Ranjan Bnerjee @deb_ranjan2]

@rajagadad17 @redBus_in @redBus_in should look into mine and your cases.

[Deb Ranjan Bnerjee @deb_ranjan2]

@Ghosh_Pokhraj @manishjana1 Congratulations

[Deb Ranjan Bnerjee @deb_ranjan2]

The EHMT2/G9a has been associated with Cancer, Alzheimer’s, and aging and is considered an emerging drug target having no clinically passed inhibitor. 
Congrats Abhisek Jana. Special Thanks to @Naturcell

[Deb Ranjan Bnerjee @deb_ranjan2]

Glad to share this latest work from my group. Herein, we report a blended ligand and structure-based pharmacophore screening approach to identify new natural leads against the Protein Lysine Methyltransferase 2 (EHMT2/G9a).

https://t.co/UHnlaJrxJP

[Deb Ranjan Bnerjee @deb_ranjan2]

What's chatGPT? What's it's purpose?
Can anyone please explain it to me in layman language?
#chatGPT

[Deb Ranjan Bnerjee @deb_ranjan2]

@Ghosh_Pokhraj Wow. Glad to you enjoying.

[Deb Ranjan Bnerjee @deb_ranjan2]

Though Dr Chattaraj is a decorated scientist with 20 patents and many inventions, still his humbleness and high spirit fueled the positivity in the discussion.
Dr Chattaraj enlightened us with the application of Chemistry beyond the academic boundaries.
#research #experience

[Deb Ranjan Bnerjee @deb_ranjan2]

Glad to experience an excellent presentation and follow-up discussion with Dr Sarnath Chattaraj (Senior Research Director, Medtronic, USA) at NIT Durgapur, India.